Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 4 Weeks and up

Using intranasal dexmedetomidine to manage pain during eye exams in premature infants

Official title: Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity: a Crossover Randomized Controlled Trial

Run by Assaf-Harofeh Medical Center · NCT06067958 · Data updated 2026-11-12

This study tests if a nasal spray of dexmedetomidine can help reduce pain for premature infants during eye exams.

More Dexmedetomidine trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages4 Weeks and up
SexAll
Enrollment30 (estimated)
SponsorAssaf-Harofeh Medical Center
Government
Locations1 site (Be’er Ya‘aqov, Center)
StatusRecruiting
StartedDecember 11, 2023
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedDecember 6, 2024
Trial IDNCT06067958 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are preterm infants with a gestational age of less than 31 weeks or a birth weight of less than 1500 grams.

Probably not a fit

Patients who are on invasive ventilation or have multiple congenital or genetic anomalies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of intranasal dexmedetomidine for pain management in preterm infants undergoing eye examinations for retinopathy of prematurity. The study compares the pain scores of infants receiving dexmedetomidine to those receiving a placebo (saline 0.9%) administered 30 minutes prior to the examination. Participants will be closely monitored for pain relief and any potential adverse effects. The goal is to improve pain management during these critical assessments, which are known to cause significant discomfort.

Why it matters

Potential benefit: If successful, this approach could significantly reduce pain and stress for preterm infants during necessary eye examinations.

How similar studies have gone: While there is limited data on the use of dexmedetomidine specifically for this purpose, similar approaches in pain management for infants have shown promise.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Gestational age \< 31 weeks post-menstrual age, or birth weight \< 1500 grams
* Informed consent signed by one of the parents

Exclusion Criteria:

* Invasive ventilation at the time of the eye assessment
* Multiple congenital anomalies
* Chromosomal / genetic anomalies
* Infant received a sedative drug in last 5 days
* Eye examination for reasons other than retinopathy of prematurity screening
* Attending physician deemed the patient not stable enough

Where it's running

  • Assaf-Harofeh Medical Center
    Be’er Ya‘aqov, Center, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.